Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer

2676.0000 -114.40 (-4.10%)

NSE Apr 25, 2025 15:31 PM

26.76% Gain from 52W Low

Volume: 68,055

Ajanta Pharma Ltd.

04 Nov 2022

2676.00

-4.10%

Ajanta Pharma (HOLD): No respite from margin pressure; cut to HOLD

Hold: Ajanta Pharma Ltd.

BOB Capital Markets Ltd.

Q2 revenue growth muted at 6% YoY as lower Africa/US sales offset a strong uptick in India/Asia business

Ajanta Pharma Ltd.'s price crossed below 100Day SMA today